High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease.
Chronic Kidney Disease (CKD) is a risk factor for cardiovascular disease (CVD), and patients with CKD have markedly higher CVD mortality compared to healthy controls. However, the relationship between specific lipoprotein profiles and new CV events in patients with advanced CKD and cardiovascular bu...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0320803 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849714094387494912 |
|---|---|
| author | Anna V Mathew Yun Han Vetalise C Konje Yanhong Guo Jaeman Byun Alexander George Julian Meza Sanjay Rajagopalan Y Eugene Chen Brenda Gillespie Rajiv Saran Subramaniam Pennathur |
| author_facet | Anna V Mathew Yun Han Vetalise C Konje Yanhong Guo Jaeman Byun Alexander George Julian Meza Sanjay Rajagopalan Y Eugene Chen Brenda Gillespie Rajiv Saran Subramaniam Pennathur |
| author_sort | Anna V Mathew |
| collection | DOAJ |
| description | Chronic Kidney Disease (CKD) is a risk factor for cardiovascular disease (CVD), and patients with CKD have markedly higher CVD mortality compared to healthy controls. However, the relationship between specific lipoprotein profiles and new CV events in patients with advanced CKD and cardiovascular burden is unknown. We profiled the distribution of High density lipoprotein (HDL) size, particle concentration, and cholesterol and triglyceride content of the baseline plasma of 325 subjects with moderate CKD followed for 2.5 years using nuclear magnetic resonance (NMR) spectroscopy. We used Cox regression models controlled for various clinical factors to characterize the role of specific HDL profiles in predicting CV events in this high-risk population. The cholesterol uptake capacity of HDL from peripheral tissues- cholesterol efflux capacity (CEC) and HDL oxidation were also quantified using standardized assays. Patients with new CV events demonstrated increased HDL size, large HDL particle numbers, and CEC. Increased HDL particle size [HR = 2.56, p = 0.002], large HDL particle numbers [HR = 1.41, p = 0.001], HDL-cholesterol levels [HR = 1.03, p = 0.008], and CEC [HR = 1.46, p = 0.03] associated with CV events. Our study demonstrates that higher HDL particle size associated with new CV events in the CKD population with a high cardiovascular burden independent of CEC and HDL cholesterol. Collectively, the data strongly associate altered lipoprotein metabolism, particularly HDL metabolism, and new CV events in patients with established CKD and CVD, allowing us to risk stratify and potentially reduce mortality and morbidity in this high-risk population. |
| format | Article |
| id | doaj-art-3f8754db69d74240aefc720d78bfb2ec |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-3f8754db69d74240aefc720d78bfb2ec2025-08-20T03:13:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01204e032080310.1371/journal.pone.0320803High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease.Anna V MathewYun HanVetalise C KonjeYanhong GuoJaeman ByunAlexander GeorgeJulian MezaSanjay RajagopalanY Eugene ChenBrenda GillespieRajiv SaranSubramaniam PennathurChronic Kidney Disease (CKD) is a risk factor for cardiovascular disease (CVD), and patients with CKD have markedly higher CVD mortality compared to healthy controls. However, the relationship between specific lipoprotein profiles and new CV events in patients with advanced CKD and cardiovascular burden is unknown. We profiled the distribution of High density lipoprotein (HDL) size, particle concentration, and cholesterol and triglyceride content of the baseline plasma of 325 subjects with moderate CKD followed for 2.5 years using nuclear magnetic resonance (NMR) spectroscopy. We used Cox regression models controlled for various clinical factors to characterize the role of specific HDL profiles in predicting CV events in this high-risk population. The cholesterol uptake capacity of HDL from peripheral tissues- cholesterol efflux capacity (CEC) and HDL oxidation were also quantified using standardized assays. Patients with new CV events demonstrated increased HDL size, large HDL particle numbers, and CEC. Increased HDL particle size [HR = 2.56, p = 0.002], large HDL particle numbers [HR = 1.41, p = 0.001], HDL-cholesterol levels [HR = 1.03, p = 0.008], and CEC [HR = 1.46, p = 0.03] associated with CV events. Our study demonstrates that higher HDL particle size associated with new CV events in the CKD population with a high cardiovascular burden independent of CEC and HDL cholesterol. Collectively, the data strongly associate altered lipoprotein metabolism, particularly HDL metabolism, and new CV events in patients with established CKD and CVD, allowing us to risk stratify and potentially reduce mortality and morbidity in this high-risk population.https://doi.org/10.1371/journal.pone.0320803 |
| spellingShingle | Anna V Mathew Yun Han Vetalise C Konje Yanhong Guo Jaeman Byun Alexander George Julian Meza Sanjay Rajagopalan Y Eugene Chen Brenda Gillespie Rajiv Saran Subramaniam Pennathur High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. PLoS ONE |
| title | High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. |
| title_full | High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. |
| title_fullStr | High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. |
| title_full_unstemmed | High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. |
| title_short | High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease. |
| title_sort | high density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease |
| url | https://doi.org/10.1371/journal.pone.0320803 |
| work_keys_str_mv | AT annavmathew highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT yunhan highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT vetaliseckonje highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT yanhongguo highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT jaemanbyun highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT alexandergeorge highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT julianmeza highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT sanjayrajagopalan highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT yeugenechen highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT brendagillespie highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT rajivsaran highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease AT subramaniampennathur highdensitylipoproteinparticlesizeandfunctionassociatewithnewcardiovasculareventsinpatientswithchronickidneydisease |